Zurcher Kantonalbank (Zurich Cantonalbank)
BankPosition in KYTX — Kyverna Therapeutics, Inc.
CIK 1368163
ZURICH, V8
Position in KYTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,058
New position
Shares Held
1,629
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Zurcher Kantonalbank (Zurich Cantonalbank) holds $538,697,913 across 179 Biotechnology names. KYTX ranks #150 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
377,013 | $168,351,385 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
365,451 | $69,088,511 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
88,871 | $68,665,289 | |
| 4 | INSM |
INSMED Inc
|
152,366 | $24,914,888 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
74,920 | $24,788,780 | |
| 6 | INCY |
Incyte Corp
|
210,788 | $19,839,366 | |
| 7 | RPRX |
Royalty Pharma plc
|
373,042 | $17,894,824 | |
| 8 | MRNA |
Moderna, Inc.
|
160,161 | $8,136,178 |
All Filings in KYTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,058 | 1,629 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||